<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0A32DF0B-F2C5-42D5-A74A-32E1FD6B47D1"><gtr:id>0A32DF0B-F2C5-42D5-A74A-32E1FD6B47D1</gtr:id><gtr:name>University of Massachusetts (UMass)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C9FF1151-E064-4E1D-9054-B4BBF5A9E5D4"><gtr:id>C9FF1151-E064-4E1D-9054-B4BBF5A9E5D4</gtr:id><gtr:name>Genetech, Inc</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/77558636-602F-416D-9BB4-73B783769BC3"><gtr:id>77558636-602F-416D-9BB4-73B783769BC3</gtr:id><gtr:name>Pfizer Ltd</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4A9426E3-7F35-48FC-BD72-3776C8F90A4A"><gtr:id>4A9426E3-7F35-48FC-BD72-3776C8F90A4A</gtr:id><gtr:name>Grants Admin Office</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Biochemistry</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0A32DF0B-F2C5-42D5-A74A-32E1FD6B47D1"><gtr:id>0A32DF0B-F2C5-42D5-A74A-32E1FD6B47D1</gtr:id><gtr:name>University of Massachusetts (UMass)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C9FF1151-E064-4E1D-9054-B4BBF5A9E5D4"><gtr:id>C9FF1151-E064-4E1D-9054-B4BBF5A9E5D4</gtr:id><gtr:name>Genetech, Inc</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/77558636-602F-416D-9BB4-73B783769BC3"><gtr:id>77558636-602F-416D-9BB4-73B783769BC3</gtr:id><gtr:name>Pfizer Ltd</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4A9426E3-7F35-48FC-BD72-3776C8F90A4A"><gtr:id>4A9426E3-7F35-48FC-BD72-3776C8F90A4A</gtr:id><gtr:name>Grants Admin Office</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/1B9F6F30-BEEC-4C65-BAB7-78F6632A3AA3"><gtr:id>1B9F6F30-BEEC-4C65-BAB7-78F6632A3AA3</gtr:id><gtr:firstName>Clare</gtr:firstName><gtr:surname>Bryant</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/FBD43890-08B8-4CE0-A3BC-DABB620D95BB"><gtr:id>FBD43890-08B8-4CE0-A3BC-DABB620D95BB</gtr:id><gtr:firstName>Nicholas</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>Gay</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/66CE5C78-9782-45C3-8587-B4314216469B"><gtr:id>66CE5C78-9782-45C3-8587-B4314216469B</gtr:id><gtr:firstName>David</gtr:firstName><gtr:surname>Klenerman</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G1000133"><gtr:id>1BC2073D-DD42-4516-BFB7-03C3E1918BC1</gtr:id><gtr:title>Molecular mechanisms of innate immune signal tranduction by the Toll-like receptor 4</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G1000133</gtr:grantReference><gtr:abstractText>Humans have evolved complex and effective ways of fighting infections caused by microbes such as bacteria and viruses, the immune system. Sometimes the immune system goes wrong and this can cause serious diseases such as rheumatoid arthritis and diabetes. Our research aims to understand at a molecular level how the cells of the immune system are able to recognise microbes and the ways in which these cells respond to cause the familiar symptoms of an infection such as fever and tiredness, and to generate specific antibodies that fight the invading microbes. In this programme we will study the way in which immune system cells respond to a powerful toxins and allergens, such as endotoxin or LPS, released by certain types of bacteria during an infection. Although normal responses to endotoxin are an important part of the fight against infection, it can cause a highly dangerous condition called endotoxic shock in patients with severe septicaemia and this pathological response frequently causes organ failure and death. In fact endotoxin shock is responsible for about 135000 deaths every year in Europe alone. The proposed studies should shed light on why endotoxin can produce a beneficial reaction in some conditions and a damaging response in others.</gtr:abstractText><gtr:technicalSummary>The discovery of pattern recogniion receptors (PRRs) is one of the most important advances in immunology of the last 20 years. One class of PRRs, the Toll-like receptors (TLRs) are now understood to play critical roles in the initiation of inflammatory responses to infection by viruses, bacteria and other microbial pathogens. TLR4, the receptor for Gram- lipopolysaccharides, is of of particular importance in this regard and recent studies have also implicated it as a key mediator of the sterile and allergic inflammatory responses charcteristic of chronic diseases such as rheumatoid arthritis and asthma. 

This Programme Grant has three objectives all of which aim to understand the molecular mechanisms of signal transduction by TLR4 and to use this information to develop novel therapies for sepsis, allergic asthma and sterile inflammation. Firstly we will use structural biology and the emerging technique of single molecule imaging to study the signal transduction process in living cells. This approach will allow us to visualise the formation of transient signalling complexes in real time and define the molecular basis of signalling specificity, the stoichiometry of the constituent subunits and the cooperativity of the signalling process. In the second part of the programme we will use biophysical, biochemical and cell based techniques to determine the mode of action of lipid bearing aeroallergens and the endogenous ligands fibronectin and tenascin C all of which activate or enhance signalling by TLR4. Finally, in collaboration with Pfizer Inc we will determine how at the structural level antagonistic antibodies directed against TLR4 are able to inhibit signalling and use structure based design to develop novel inhibitors of TLR4 for use in the treatment of endotoxic shock and other inflammatory diseases mediated by TLR4.</gtr:technicalSummary><gtr:fund><gtr:end>2015-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2010-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1741899</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Massachusetts (UMass)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>University of Massachusetts Medical School</gtr:department><gtr:description>Doug Golenbock, University of Massachusetts Medical School</gtr:description><gtr:id>C56F8E89-9322-40CB-93EE-ADD3C343F85B</gtr:id><gtr:outcomeId>b95f35e8b95f35fc-1</gtr:outcomeId><gtr:piContribution>I went on sabbatical to the Golenock laboratory for 2 months in 2008</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>GlaxoSmithKline (GSK)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>GSK Immunology Catalyst Sabbatical Award</gtr:description><gtr:id>5E59FF77-60B0-4B6E-98AA-BBAEB239F991</gtr:id><gtr:impact>None yet</gtr:impact><gtr:outcomeId>58bea4f2263ab3.75559105-1</gtr:outcomeId><gtr:partnerContribution>GSK bought out my teaching and administration duties for 3 years and fund 2 postdoctoral researchers to work with me at GSK</gtr:partnerContribution><gtr:piContribution>GSK have bought out my teaching and administration duties for 3 years. I spend 3 days a week at GSK and have 2 postdoctoral researchers at GSK. I am working on inflammasome biology and Pattern Recognition Receptor research. I intellectually input into several of the GSK therapeutic units.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Massachusetts (UMass)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>University of Massachusetts Medical School</gtr:department><gtr:description>International and national collaboration with Eicke Laetz</gtr:description><gtr:id>8DB23FBC-3DF9-4E14-829E-5DB05FF96F9D</gtr:id><gtr:outcomeId>b95f36e2b95f36f6-1</gtr:outcomeId><gtr:piContribution>University of Massachusetts Medical School</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Massachusetts (UMass)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>University of Massachusetts Medical School</gtr:department><gtr:description>Continued Collaboration with University of Massachusetts Medical Schoo</gtr:description><gtr:id>112C91F3-92F9-48B6-944A-BD5AB7566746</gtr:id><gtr:impact>On going provision of reagents has enabled our publications for this grant.</gtr:impact><gtr:outcomeId>b960d6dcb960d6f0-1</gtr:outcomeId><gtr:partnerContribution>Provision of cell lines and reagents. Intellectual discussions about our research work.</gtr:partnerContribution><gtr:piContribution>Continuation of existing collaboration</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Trinity College Dublin</gtr:collaboratingOrganisation><gtr:country>Ireland, Republic of</gtr:country><gtr:description>Luke O'Neill, Trinity College, Dublin</gtr:description><gtr:id>B9182455-1E75-4B94-9B8E-373407D1C62D</gtr:id><gtr:impact>Publications</gtr:impact><gtr:outcomeId>b95f34eeb95f3502-1</gtr:outcomeId><gtr:partnerContribution>Intellectual input
Collaborative discussion
Transfer of new techniques</gtr:partnerContribution><gtr:piContribution>Collaboration with Trinity College, Dublin</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Massachusetts (UMass)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>University of Massachusetts Medical School</gtr:department><gtr:description>International and national collaborations with Kate Fitzgerald</gtr:description><gtr:id>7FA14E18-A5A9-4C21-B82D-64CD5A147186</gtr:id><gtr:impact>Publications linked to our research grants have been facilitated by this collaboration.</gtr:impact><gtr:outcomeId>b95f3bceb95f3be2-1</gtr:outcomeId><gtr:partnerContribution>Provision of reagents, cell lines and intellectual input to our research.</gtr:partnerContribution><gtr:piContribution>Intellectual input and collaborative discussions about common research interests.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Genetech, Inc</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Genentech Visiting Professorship</gtr:description><gtr:id>D1D208FE-5E0E-43FD-9AB7-B8D16BC50E42</gtr:id><gtr:impact>None yet as the work is still in progress</gtr:impact><gtr:outcomeId>58bea1c5e94e86.75233010-1</gtr:outcomeId><gtr:partnerContribution>My collaborators gave me novel reagents and supported my research during my time in the USA</gtr:partnerContribution><gtr:piContribution>I visited Genentech South San Francisco site and performed research in the laboratory there for 9 months. Two of my PhD students also had 3 month internships working with myself and my Genentech collaborators. We learnt new techniques and gained access to new reagents. I intellectually contributed to their inflammasome research program.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pfizer Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Immunology and Microbiology</gtr:department><gtr:description>Non-competitive inhibitors of TLR4</gtr:description><gtr:id>65BE7B24-D533-4CC7-81F1-B5D376FF5238</gtr:id><gtr:impact>Subject to NDA</gtr:impact><gtr:outcomeId>JdgLdfkqHKB-1</gtr:outcomeId><gtr:partnerContribution>Materials (antibodies)</gtr:partnerContribution><gtr:piContribution>Molecular basis of antagonism</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Recognition of bacterial infection by Pattern recognition receptors</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>5679BD7F-87ED-48FF-9C71-8BA62A520993</gtr:id><gtr:impact>NIH NIAID, Bethesda, USA

no actual impacts realised to date</gtr:impact><gtr:outcomeId>r-4477234123.7191430beb5e26</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research or patient groups</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Recognition of bacterial infection by Pattern recognition receptors</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C60347B2-CB52-47AA-B3BF-4D4D0F763350</gtr:id><gtr:impact>Talk to University of Massachusetts Medical School, Worcester, USA

no actual impacts realised to date</gtr:impact><gtr:outcomeId>r-651868209.84992040bec7f40</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research or patient groups</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Queens College Academic Saturday 2014: Why cats make you sneeze</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>DF463F27-E8D0-4FEE-9ACF-0ABBE53103F9</gtr:id><gtr:impact>Public engagement

No notable impact yet</gtr:impact><gtr:outcomeId>544e5463eec0a3.45785018</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:url>http://www.queens.cam.ac.uk/life-at-queens/news-and-events/academic-saturday-11th-october</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Lafferty Debate participant</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>ADC289CD-8EFD-44E6-BCD8-642EB5E42DF3</gtr:id><gtr:impact>Participated in a public debate on &amp;quot;Adaptive Immunity is innately redundant&amp;quot;</gtr:impact><gtr:outcomeId>58bebfd38e8595.88528426</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Pattern recognition receptors: the key to host recognition of infection or a load of old PAMPs</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>7930F70D-2CFC-4585-A449-2F9EC5117870</gtr:id><gtr:impact>Invited talk

no actual impacts realised to date</gtr:impact><gtr:outcomeId>r-2958661842.1214280bb98482</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Institute for Child Heath, London (2011):Pattern recognition receptors: the key to host recognition of infection or a load of old PAMPs</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>E8413DA3-7567-4806-B03C-B6341D843028</gtr:id><gtr:impact>Institute for Child Heath, London

no actual impacts realised to date</gtr:impact><gtr:outcomeId>r-977243493.28991350cdc23b0</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Pattern recognition receptors: the key to host recognition of infection or a load of old PAMPs</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>E9F6855F-E9AA-4F1D-8B2E-2E5419C1ED7F</gtr:id><gtr:impact>Invited talk

no actual impacts realised to date</gtr:impact><gtr:outcomeId>r-3021184329.89454270ba23ce6</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>University of Maryland, USA: Pattern recognition receptors: the key to host recognition of infection or a load of old PAMPs</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>06751F70-BC94-4401-96DB-35CFB4FB6297</gtr:id><gtr:impact>Invited talk at University of Maryland, USA

no actual impacts realised to date</gtr:impact><gtr:outcomeId>r-8380735803.7500980cdc10c8</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Pattern recognition receptors: the key to host recognition of infection or a load of old PAMPs</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>947950F5-1086-4E1F-A181-44ED23425D08</gtr:id><gtr:impact>Invited talk

no actual impacts realised to date</gtr:impact><gtr:outcomeId>r-5593890711.2869350ba29d58</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research or patient groups</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Pattern recognition receptors: the key to host recognition of infection or a load of old PAMPs</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>F2D5591E-2109-4103-A78E-9BB7BA8FC68E</gtr:id><gtr:impact>Invited talk Institute for Child Health

no actual impacts realised to date</gtr:impact><gtr:outcomeId>r-7548329418.1044490bb9c0aa</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Recognition of bacterial infection by Pattern recognition receptors</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>71C9D7BC-9ECE-4A42-8A05-7FE5538208C9</gtr:id><gtr:impact>Invited talk NIAID/NIH

no actual impacts realised to date</gtr:impact><gtr:outcomeId>r-3313191564.11401130becc90a</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research or patient groups</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cambridge Alumni Festival 2014: Why cats make you sneeze</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A054B67D-3074-4CAE-8C31-6664D04F853B</gtr:id><gtr:impact>Public engagement

No notable impacts yet</gtr:impact><gtr:outcomeId>544e531cecb3c9.15935558</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.alumni.cam.ac.uk/events/alumni-festival-2014/further-information</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Recognition of bacterial infection by Pattern recognition receptors</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B53051D9-C8A2-4C20-81D4-75E2509E6C81</gtr:id><gtr:impact>Invited talk

no actual impacts realised to date</gtr:impact><gtr:outcomeId>r-9495653593.4430120be9c868</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research or patient groups</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Pattern recognition receptors: therapeutic targets for allergic as well as infectious diseases</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>7A204BE5-2EDE-45D2-8B6B-471377B762F1</gtr:id><gtr:impact>Invited talk CIMR

no actual impacts realised to date</gtr:impact><gtr:outcomeId>r-4880253127.6645630cdc0858</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research or patient groups</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cambridge Science Fair 2014: Why cats make you sneeze?</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D8F404AB-02C0-45F1-952E-74035C691C92</gtr:id><gtr:impact>Public engagement

No impact to date</gtr:impact><gtr:outcomeId>544e49018ca1d8.03754065</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.cam.ac.uk/science-festival/2014-festival</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Pattern recognition receptors: therapeutic targets for allergic as well as infectious diseases</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>local</gtr:geographicReach><gtr:id>E7B7D06F-F37B-4386-A9A8-79BF8FB41547</gtr:id><gtr:impact>Invited talk at Cambridge Institute for Medical Research, Cambridge.

no actual impacts realised to date</gtr:impact><gtr:outcomeId>r-5832447554.7600980be9ade2</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research or patient groups</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Pattern recognition receptors: the key to host recognition of infection or a load of old PAMPs</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>53BF124D-3B22-4AB3-BB79-81EA0CCAC101</gtr:id><gtr:impact>Talk to the University of Maryland, Baltimore, USA

no actual impacts realised to date</gtr:impact><gtr:outcomeId>r-7628979950.7977250be8e646</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research or patient groups</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>267000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Royal Society Wolfson Refurbishment Scheme</gtr:description><gtr:end>2018-02-02</gtr:end><gtr:fundingOrg>The Royal Society</gtr:fundingOrg><gtr:id>5EBB9613-19EE-472D-8B0A-8CFA0842B240</gtr:id><gtr:outcomeId>56b289997518d2.05135438</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>250000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC Equipment Grant</gtr:description><gtr:end>2008-09-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>A84426C4-E23B-402E-8158-A795CA25A404</gtr:id><gtr:outcomeId>B438F89ECEF0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2007-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2374355</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Investigator Award</gtr:description><gtr:end>2021-02-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef>100321/z/12/z</gtr:fundingRef><gtr:id>717E2935-79C1-46C7-A813-710F4595F445</gtr:id><gtr:outcomeId>qxNKVFoCdw9</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1600000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC Project Grant</gtr:description><gtr:end>2012-12-02</gtr:end><gtr:fundingOrg>CHDI Foundation</gtr:fundingOrg><gtr:id>FD2B6DA6-92E2-4994-AFC9-B4E0C00E552B</gtr:id><gtr:outcomeId>CADF77E261C0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>11000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>International Joint Project</gtr:description><gtr:end>2010-09-02</gtr:end><gtr:fundingOrg>The Royal Society</gtr:fundingOrg><gtr:id>A4103A8C-356D-4DC9-B49C-30F1F3974EA8</gtr:id><gtr:outcomeId>89BCA39547E0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>226000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Elion and Black Immunology Catalyst Sabbatical Award</gtr:description><gtr:end>2019-10-02</gtr:end><gtr:fundingOrg>GlaxoSmithKline (GSK)</gtr:fundingOrg><gtr:id>DE181234-96C8-4D9E-AB7A-F80570121FF7</gtr:id><gtr:outcomeId>56c3aee548a740.84843292</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2016-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>204000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Interdisciplinary Research Grant</gtr:description><gtr:end>2018-01-02</gtr:end><gtr:fundingOrg>Alzheimer's Research UK</gtr:fundingOrg><gtr:fundingRef>ARUK-IRG2014-13</gtr:fundingRef><gtr:id>E479C722-7FF9-46B0-99C0-B7955FDFF9C6</gtr:id><gtr:outcomeId>545798555e4953.51071796</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-02-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Methods for quantifying signalling</gtr:description><gtr:id>EF7EC4F8-9A13-4EEB-BF1C-024AB5741250</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>2BB2B6552ED</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Signalling assays</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>preparations of the allergen feld1</gtr:description><gtr:id>0F75A974-9A98-4390-BB5F-232BE97783D4</gtr:id><gtr:impact>Paper in preparation</gtr:impact><gtr:outcomeId>DjRhNjKTovk</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>feld1</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs><gtr:spinOutOutput><gtr:companyName>Polypharmakos</gtr:companyName><gtr:description>Spin out company with Monique Simmonds (Kew), Mark Holmes (Cambridge), Duncan Maskell (Cambridge) to screen natural products for antimicrobial and innate immune activity.</gtr:description><gtr:id>5ACB3360-E871-4158-8C74-B3F5A5C18FDA</gtr:id><gtr:impact>None Yet</gtr:impact><gtr:outcomeId>58beaac49b7409.74594677</gtr:outcomeId><gtr:url>http://www.polypharmakos.com/</gtr:url><gtr:yearCompanyFormed>2016</gtr:yearCompanyFormed></gtr:spinOutOutput></gtr:spinOutOutputs></gtr:output><gtr:publications><gtr:publication><gtr:id>1F54E3B7-8AA6-411E-B239-8EC075422E43</gtr:id><gtr:title>Conserved mechanisms of signal transduction by Toll and Toll-like receptors.</gtr:title><gtr:parentPublicationTitle>Journal of endotoxin research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9ff98c72898a01ac75c133f78b4e23cf"><gtr:id>9ff98c72898a01ac75c133f78b4e23cf</gtr:id><gtr:otherNames>Gangloff M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0968-0519</gtr:issn><gtr:outcomeId>FB4ACD2AD19</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B0E3E8C0-3A6E-4059-9D1B-5710F990A8D7</gtr:id><gtr:title>Advances in Toll-like receptor biology: Modes of activation by diverse stimuli.</gtr:title><gtr:parentPublicationTitle>Critical reviews in biochemistry and molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dc38ddc2aa13707bc8b3e3c7d2d3829c"><gtr:id>dc38ddc2aa13707bc8b3e3c7d2d3829c</gtr:id><gtr:otherNames>Bryant CE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1040-9238</gtr:issn><gtr:outcomeId>585d58c22ed467.80346022</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>44D470AC-333F-499E-82D8-DE602576E125</gtr:id><gtr:title>Liesegang-like patterns of Toll crystals grown in gel.</gtr:title><gtr:parentPublicationTitle>Journal of applied crystallography</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9ff98c72898a01ac75c133f78b4e23cf"><gtr:id>9ff98c72898a01ac75c133f78b4e23cf</gtr:id><gtr:otherNames>Gangloff M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0021-8898</gtr:issn><gtr:outcomeId>pm_15585_25_23596340</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9C22D9B5-9DCA-43CE-A8AC-599BD3FAE9A3</gtr:id><gtr:title>Allergens as immunomodulatory proteins: the cat dander protein Fel d 1 enhances TLR activation by lipid ligands.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5ea11c8b56c3c9b25d69cbb473a5cc1b"><gtr:id>5ea11c8b56c3c9b25d69cbb473a5cc1b</gtr:id><gtr:otherNames>Herre J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>5456c2553d9b38.21426410</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E4C08D04-85B6-4974-9C9C-11BF64C749B5</gtr:id><gtr:title>The molecular basis of the host response to lipopolysaccharide.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dc38ddc2aa13707bc8b3e3c7d2d3829c"><gtr:id>dc38ddc2aa13707bc8b3e3c7d2d3829c</gtr:id><gtr:otherNames>Bryant CE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1740-1526</gtr:issn><gtr:outcomeId>A088ED592C1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>533E8AE9-7AC7-4EA1-8E35-1C421A02FE6C</gtr:id><gtr:title>An alanine-to-proline mutation in the BB-loop of TLR3 Toll/IL-1R domain switches signalling adaptor specificity from TRIF to MyD88.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fac8f94735a592656a288b83b30e92cd"><gtr:id>fac8f94735a592656a288b83b30e92cd</gtr:id><gtr:otherNames>Verstak B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>pm_15585_25_24198284</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>099DC384-DF32-45E9-A8D1-C47B864A665F</gtr:id><gtr:title>Assembly and localization of Toll-like receptor signalling complexes.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a7af28f06edb07f35fdd2d1d85b73704"><gtr:id>a7af28f06edb07f35fdd2d1d85b73704</gtr:id><gtr:otherNames>Gay NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1474-1733</gtr:issn><gtr:outcomeId>56b28242eac8a4.54474036</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4A9869C3-62AB-4606-85EE-DCE131A042A1</gtr:id><gtr:title>What the Myddosome structure tells us about the initiation of innate immunity.</gtr:title><gtr:parentPublicationTitle>Trends in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a7af28f06edb07f35fdd2d1d85b73704"><gtr:id>a7af28f06edb07f35fdd2d1d85b73704</gtr:id><gtr:otherNames>Gay NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1471-4906</gtr:issn><gtr:outcomeId>pm_15585_25_21269878</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>28C03A85-08F3-46AD-AD8B-4CCCCD1A91A4</gtr:id><gtr:title>Functional insights from the crystal structure of the N-terminal domain of the prototypical toll receptor.</gtr:title><gtr:parentPublicationTitle>Structure (London, England : 1993)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9ff98c72898a01ac75c133f78b4e23cf"><gtr:id>9ff98c72898a01ac75c133f78b4e23cf</gtr:id><gtr:otherNames>Gangloff M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0969-2126</gtr:issn><gtr:outcomeId>pm_15585_25_23245851</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>302FF4AC-9233-4B2B-9793-8BF14C785A17</gtr:id><gtr:title>Molecular mechanism that induces activation of Sp&amp;auml;tzle, the ligand for the Drosophila Toll receptor.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c8a204c64998cf08544e7288ff30d6c0"><gtr:id>c8a204c64998cf08544e7288ff30d6c0</gtr:id><gtr:otherNames>Arnot CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_15585_25_20378549</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>29972614-5E27-495D-9118-67BFB2255563</gtr:id><gtr:title>Critical residues involved in Toll-like receptor 4 activation by cationic lipid nanocarriers are not located at the lipopolysaccharide-binding interface.</gtr:title><gtr:parentPublicationTitle>Cell Mol Life Sci</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/73bb9ac7e3fea6bd83d25e6e152ed9bb"><gtr:id>73bb9ac7e3fea6bd83d25e6e152ed9bb</gtr:id><gtr:otherNames>Lonez C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>25956320</gtr:issn><gtr:outcomeId>56b27e46d784a3.93818365</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>399F29FC-D73B-40F8-82D2-4A4402ECE7AB</gtr:id><gtr:title>Structure of the glycosyltransferase EryCIII in complex with its activating P450 homologue EryCII.</gtr:title><gtr:parentPublicationTitle>Journal of molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b5297648d9f7c1a4f578f5aebca5f1f6"><gtr:id>b5297648d9f7c1a4f578f5aebca5f1f6</gtr:id><gtr:otherNames>Moncrieffe MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-2836</gtr:issn><gtr:outcomeId>pm_15585_25_22056329</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3C6AAF6C-CF53-4262-B423-21A16C28E1F8</gtr:id><gtr:title>Two human MYD88 variants, S34Y and R98C, interfere with MyD88-IRAK4-myddosome assembly.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/04612eb13fa31d0236e102d8529322f2"><gtr:id>04612eb13fa31d0236e102d8529322f2</gtr:id><gtr:otherNames>George J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_15585_25_20966070</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FEB6BEE1-7814-4E25-81BE-5DADB4D04DE9</gtr:id><gtr:title>Cytokine Spatzle binds to the Drosophila immunoreceptor Toll with a neurotrophin-like specificity and couples receptor activation.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5648bff053d2d7a3157487f9d9f04d77"><gtr:id>5648bff053d2d7a3157487f9d9f04d77</gtr:id><gtr:otherNames>Lewis M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>doi_55faa1aa1fed1116</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7253C005-E364-4B64-BA38-83BBE71CCA8B</gtr:id><gtr:title>Therapeutic administration of recombinant Paracoccin confers protection against paracoccidioides brasiliensis infection: involvement of TLRs.</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/18795528caf80588437c382eef5819b6"><gtr:id>18795528caf80588437c382eef5819b6</gtr:id><gtr:otherNames>Alegre-Maller AC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn><gtr:outcomeId>doi_55faa2aa2000499a</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CDD4F7C0-F08F-4C4D-8E4F-5EFF3ED999F0</gtr:id><gtr:title>Toll-like receptors as molecular switches.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a7af28f06edb07f35fdd2d1d85b73704"><gtr:id>a7af28f06edb07f35fdd2d1d85b73704</gtr:id><gtr:otherNames>Gay NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1474-1733</gtr:issn><gtr:outcomeId>79682B30F6D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2A4A672D-FB0C-46DD-9026-9747B7F96273</gtr:id><gtr:title>Sensing of Gram-positive bacteria in Drosophila: GNBP1 is needed to process and present peptidoglycan to PGRP-SA.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c4fb28c7b7f759ed5da54d4f587d639a"><gtr:id>c4fb28c7b7f759ed5da54d4f587d639a</gtr:id><gtr:otherNames>Wang L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>154B21D8EB1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D6B81385-7BB2-4990-8B3E-565EE243B882</gtr:id><gtr:title>Toll-6 and Toll-7 function as neurotrophin receptors in the Drosophila melanogaster CNS.</gtr:title><gtr:parentPublicationTitle>Nature neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4e40a0c827dfd1224a9de34d2729d793"><gtr:id>4e40a0c827dfd1224a9de34d2729d793</gtr:id><gtr:otherNames>McIlroy G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1097-6256</gtr:issn><gtr:outcomeId>pm_15585_25_23892553</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0384DBFB-197B-4354-A9C3-69A51B80C5A0</gtr:id><gtr:title>Activation of Toll-like receptors nucleates assembly of the MyDDosome signaling hub.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/96679259ad3b8888bb7ca701e5756efe"><gtr:id>96679259ad3b8888bb7ca701e5756efe</gtr:id><gtr:otherNames>Latty S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn><gtr:outcomeId>5a90460d38a286.69286409</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E9AD798F-2033-42F0-8417-4B79C45F321D</gtr:id><gtr:title>Energetics of Endotoxin Recognition in the Toll-Like Receptor 4 Innate Immune Response.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/770c2fe5cc77733e7ef1ee520d315165"><gtr:id>770c2fe5cc77733e7ef1ee520d315165</gtr:id><gtr:otherNames>Paramo T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>56b26768843cf0.34319532</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8BEAA626-98A5-4573-8DFF-D9E80479D290</gtr:id><gtr:title>Conserved features in the extracellular domain of human toll-like receptor 8 are essential for pH-dependent signaling.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/991185143b0742bc16b67df53ce80c7b"><gtr:id>991185143b0742bc16b67df53ce80c7b</gtr:id><gtr:otherNames>Gibbard RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>4ACD2C52F1F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>437CA1A3-C406-4C0F-A979-1B0CA923CE1C</gtr:id><gtr:title>Crystal structure of Toll-like receptor adaptor MAL/TIRAP reveals the molecular basis for signal transduction and disease protection.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8052dc958bb199668ea5cf44fab03d60"><gtr:id>8052dc958bb199668ea5cf44fab03d60</gtr:id><gtr:otherNames>Valkov E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_15585_25_21873236</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0A501062-4147-44F6-9ABA-BDFB5A3C6628</gtr:id><gtr:title>Structure and function of Toll receptors and their ligands.</gtr:title><gtr:parentPublicationTitle>Annual review of biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a7af28f06edb07f35fdd2d1d85b73704"><gtr:id>a7af28f06edb07f35fdd2d1d85b73704</gtr:id><gtr:otherNames>Gay NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0066-4154</gtr:issn><gtr:outcomeId>86A4C1E9683</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>09C91DEB-A390-480F-9867-FF7AF60C1C82</gtr:id><gtr:title>The COP II adaptor protein TMED7 is required to initiate and mediate the delivery of TLR4 to the plasma membrane.</gtr:title><gtr:parentPublicationTitle>Science signaling</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b6259d72b204377289e1ffe0a6957849"><gtr:id>b6259d72b204377289e1ffe0a6957849</gtr:id><gtr:otherNames>Liaunardy-Jopeace A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1945-0877</gtr:issn><gtr:outcomeId>585d76b5283450.32019321</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6F002410-C80B-4745-9ED9-F27FBA241502</gtr:id><gtr:title>The TLR signaling adaptor TRAM interacts with TRAF6 to mediate activation of the inflammatory response by TLR4.</gtr:title><gtr:parentPublicationTitle>Journal of leukocyte biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fac8f94735a592656a288b83b30e92cd"><gtr:id>fac8f94735a592656a288b83b30e92cd</gtr:id><gtr:otherNames>Verstak B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0741-5400</gtr:issn><gtr:outcomeId>5460af537af4e2.37925476</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AD7DCF52-E2BB-49B8-A18E-DBB28864A97C</gtr:id><gtr:title>Structural insight into the mechanism of activation of the Toll receptor by the dimeric ligand Sp&amp;auml;tzle.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9ff98c72898a01ac75c133f78b4e23cf"><gtr:id>9ff98c72898a01ac75c133f78b4e23cf</gtr:id><gtr:otherNames>Gangloff M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>5B86071F1E5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>70BF7B31-7B6A-42EA-9EAC-298EDA3BD79D</gtr:id><gtr:title>Activation of innate immunity by lysozyme fibrils is critically dependent on cross-? sheet structure.</gtr:title><gtr:parentPublicationTitle>Cellular and molecular life sciences : CMLS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b0013d1e73ab76b2d112992473ceb00"><gtr:id>9b0013d1e73ab76b2d112992473ceb00</gtr:id><gtr:otherNames>Gustot A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1420-682X</gtr:issn><gtr:outcomeId>5456dedcae4b16.59915941</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1ACF0996-EE9E-4E5C-99BB-BC21945DEF4E</gtr:id><gtr:title>Assembly of oligomeric death domain complexes during Toll receptor signaling.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b5297648d9f7c1a4f578f5aebca5f1f6"><gtr:id>b5297648d9f7c1a4f578f5aebca5f1f6</gtr:id><gtr:otherNames>Moncrieffe MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>1108B00F732</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B683598D-E53A-4E99-BBD4-EDC17D6F2CB6</gtr:id><gtr:title>Critical residues involved in Toll-like receptor 4 activation by cationic lipid nanocarriers are not located at the lipopolysaccharide-binding interface.</gtr:title><gtr:parentPublicationTitle>Cellular and molecular life sciences : CMLS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/73bb9ac7e3fea6bd83d25e6e152ed9bb"><gtr:id>73bb9ac7e3fea6bd83d25e6e152ed9bb</gtr:id><gtr:otherNames>Lonez C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1420-682X</gtr:issn><gtr:outcomeId>56b28243838cb4.32089152</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6179731E-662D-4AB9-9418-7B9E3C3B5D57</gtr:id><gtr:title>Trif-related adapter molecule is phosphorylated by PKC{epsilon} during Toll-like receptor 4 signaling.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/88af4d55620269caaa68385e78cb95cb"><gtr:id>88af4d55620269caaa68385e78cb95cb</gtr:id><gtr:otherNames>McGettrick AF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>27DA5BB3E21</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>86A36930-6630-4AF0-BEAE-E83DCF3AEA8A</gtr:id><gtr:title>Identification of key residues that confer Rhodobacter sphaeroides LPS activity at horse TLR4/MD-2.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c87c4c5eb7bc2d882f389aea64ad9859"><gtr:id>c87c4c5eb7bc2d882f389aea64ad9859</gtr:id><gtr:otherNames>Irvine KL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5456b6b3a3c969.69266939</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>54582B38-3081-49D6-9A8B-F457A2895DF4</gtr:id><gtr:title>Toll-like receptor signalling through macromolecular protein complexes.</gtr:title><gtr:parentPublicationTitle>Molecular immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dc38ddc2aa13707bc8b3e3c7d2d3829c"><gtr:id>dc38ddc2aa13707bc8b3e3c7d2d3829c</gtr:id><gtr:otherNames>Bryant CE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0161-5890</gtr:issn><gtr:outcomeId>56b28244323ca9.09903508</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4405AEB7-5BC2-458E-9EAD-F4E0D4E9108D</gtr:id><gtr:title>Adaptors in toll-like receptor signaling and their potential as therapeutic targets.</gtr:title><gtr:parentPublicationTitle>Current drug targets</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9e1d069c104df2c24657554a64d8fba6"><gtr:id>9e1d069c104df2c24657554a64d8fba6</gtr:id><gtr:otherNames>Ve T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1389-4501</gtr:issn><gtr:outcomeId>pm_15585_25_22664090</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CEA0AD6F-5805-4C24-A921-9736440B7330</gtr:id><gtr:title>Bioinformatic analysis of Toll-like receptor sequences and structures.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2bdbcc6c899882f237eac5d622f63da8"><gtr:id>2bdbcc6c899882f237eac5d622f63da8</gtr:id><gtr:otherNames>Monie TP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>76A7C16F9B9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9C22501B-DF76-4723-9A55-7BF1473D8D13</gtr:id><gtr:title>The structural basis for endotoxin-induced allosteric regulation of the Toll-like receptor 4 (TLR4) innate immune receptor.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/770c2fe5cc77733e7ef1ee520d315165"><gtr:id>770c2fe5cc77733e7ef1ee520d315165</gtr:id><gtr:otherNames>Paramo T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>5456c0ce1ac277.59790770</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3EFF1E8E-1D08-41FA-BC46-E441B49F1C96</gtr:id><gtr:title>The TLR4 D299G and T399I SNPs are constitutively active to up-regulate expression of Trif-dependent genes.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb780308ed4b3a47b85d3c436b014ea0"><gtr:id>bb780308ed4b3a47b85d3c436b014ea0</gtr:id><gtr:otherNames>Hold GL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>56b28243325644.64181516</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A8446105-29EF-410A-8FF7-D2CCB6C234E9</gtr:id><gtr:title>Lipopolysaccharide-induced NF-?B nuclear translocation is primarily dependent on MyD88, but TNFa expression requires TRIF and MyD88.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/982db68136bc0805ca8cca9fac8a1822"><gtr:id>982db68136bc0805ca8cca9fac8a1822</gtr:id><gtr:otherNames>Sakai J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>5a9043526b30b2.50615221</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D064C991-FDFB-4DC9-868C-EB5DE7490C2D</gtr:id><gtr:title>Three tier regulation of cell number plasticity by neurotrophins and Tolls in Drosophila</gtr:title><gtr:parentPublicationTitle>Mechanisms of Development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1a3e6aa92a2ea24e9c825c051814c6bf"><gtr:id>1a3e6aa92a2ea24e9c825c051814c6bf</gtr:id><gtr:otherNames>Foldi I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5a616b163d3057.71560239</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A7414428-10A5-4435-8BDE-8F67AF1B65F8</gtr:id><gtr:title>Molecular and cellular regulation of toll-like receptor-4 activity induced by lipopolysaccharide ligands.</gtr:title><gtr:parentPublicationTitle>Frontiers in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b6259d72b204377289e1ffe0a6957849"><gtr:id>b6259d72b204377289e1ffe0a6957849</gtr:id><gtr:otherNames>Liaunardy-Jopeace A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1664-3224</gtr:issn><gtr:outcomeId>5460af544d3469.79872066</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A841D95F-E8C4-486E-832D-84157C809F33</gtr:id><gtr:title>The N-terminal loop of IRAK-4 death domain regulates ordered assembly of the Myddosome signalling scaffold.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/20aac4c0b3cd57f1030522a8d2951464"><gtr:id>20aac4c0b3cd57f1030522a8d2951464</gtr:id><gtr:otherNames>Dossang AC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>58af2a8cef7720.15256629</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>746C4857-C8B7-4CAC-8EC0-DC98443B3C7F</gtr:id><gtr:title>A quantitative comparison of single-dye tracking analysis tools using Monte Carlo simulations.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/31c648d38d66f50de331bc27c1d93ec9"><gtr:id>31c648d38d66f50de331bc27c1d93ec9</gtr:id><gtr:otherNames>Weimann L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5456bc526ff2f1.98693577</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6DF53C21-38A8-48E3-A426-D51897E6F628</gtr:id><gtr:title>Activating immunity: lessons from the TLRs and NLRs.</gtr:title><gtr:parentPublicationTitle>Trends in biochemical sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2bdbcc6c899882f237eac5d622f63da8"><gtr:id>2bdbcc6c899882f237eac5d622f63da8</gtr:id><gtr:otherNames>Monie TP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0968-0004</gtr:issn><gtr:outcomeId>061B68E8352</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8CF6B909-E023-46BA-9618-3FDFA034AB30</gtr:id><gtr:title>An oligomeric signaling platform formed by the Toll-like receptor signal transducers MyD88 and IRAK-4.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/55def6e19457a0e5921289f3119168f1"><gtr:id>55def6e19457a0e5921289f3119168f1</gtr:id><gtr:otherNames>Motshwene PG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>89AB8ACEA29</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E3F9C7A6-354B-4849-AADC-CB41752CE0AA</gtr:id><gtr:title>A dimer of the Toll-like receptor 4 cytoplasmic domain provides a specific scaffold for the recruitment of signalling adaptor proteins.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35802cf40845b7f5723d894c28ef3d22"><gtr:id>35802cf40845b7f5723d894c28ef3d22</gtr:id><gtr:otherNames>N??ez Miguel R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>8E4646A44F6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>91A4A734-1171-41CD-A88B-23A1B200D975</gtr:id><gtr:title>A TIR domain variant of MyD88 adapter-like (Mal)/TIRAP results in loss of MyD88 binding and reduced TLR2/TLR4 signaling.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/16c9d853ef36f7106631c349894b125d"><gtr:id>16c9d853ef36f7106631c349894b125d</gtr:id><gtr:otherNames>Nagpal K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>75E09CC0E2D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EEF165D0-DE9D-4FCF-835D-DB6C6B5EC508</gtr:id><gtr:title>Role of the Spatzle Pro-domain in the generation of an active toll receptor ligand.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a76f77a2758d5c1e8a1193ab3b8df478"><gtr:id>a76f77a2758d5c1e8a1193ab3b8df478</gtr:id><gtr:otherNames>Weber AN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>7DEEF9C088A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9DC7C0F5-54C9-4CBB-9B48-5275702BB3F6</gtr:id><gtr:title>MD-2: the Toll 'gatekeeper' in endotoxin signalling.</gtr:title><gtr:parentPublicationTitle>Trends in biochemical sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9ff98c72898a01ac75c133f78b4e23cf"><gtr:id>9ff98c72898a01ac75c133f78b4e23cf</gtr:id><gtr:otherNames>Gangloff M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0968-0004</gtr:issn><gtr:outcomeId>A1319044CAF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>304B69F8-EABD-4BA0-8881-A87162F49E9E</gtr:id><gtr:title>The myristoylation of TRIF-related adaptor molecule is essential for Toll-like receptor 4 signal transduction.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d72101a36c91172d40e63d2015f96c24"><gtr:id>d72101a36c91172d40e63d2015f96c24</gtr:id><gtr:otherNames>Rowe DC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>34201279B61</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>73C63DA4-D73B-44E9-A140-E95A74521AEF</gtr:id><gtr:title>Elucidation of the MD-2/TLR4 interface required for signaling by lipid IVa.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70b93ce1240a36e8bf072ecb566842f1"><gtr:id>70b93ce1240a36e8bf072ecb566842f1</gtr:id><gtr:otherNames>Walsh C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>20441A3BC63</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8D18F627-C352-425F-9FC7-89FC5171F5AC</gtr:id><gtr:title>Peptidoglycan recognition protein-SD provides versatility of receptor formation in Drosophila immunity.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c4fb28c7b7f759ed5da54d4f587d639a"><gtr:id>c4fb28c7b7f759ed5da54d4f587d639a</gtr:id><gtr:otherNames>Wang L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>866E4609FE0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C9A2E710-9012-49D4-876A-BCEA427D2847</gtr:id><gtr:title>Structure and regulation of cytoplasmic adapter proteins involved in innate immune signaling.</gtr:title><gtr:parentPublicationTitle>Immunological reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2bdbcc6c899882f237eac5d622f63da8"><gtr:id>2bdbcc6c899882f237eac5d622f63da8</gtr:id><gtr:otherNames>Monie TP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0105-2896</gtr:issn><gtr:outcomeId>2B55AB5DDC6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D18B30AF-DC94-404D-A881-3A90F92141F7</gtr:id><gtr:title>Activation of insect and vertebrate toll signaling: from endogenous cytokine ligand to direct recognition of pathogen patterns.</gtr:title><gtr:parentPublicationTitle>Advances in experimental medicine and biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a7af28f06edb07f35fdd2d1d85b73704"><gtr:id>a7af28f06edb07f35fdd2d1d85b73704</gtr:id><gtr:otherNames>Gay NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0065-2598</gtr:issn><gtr:outcomeId>FB3C35C9B5A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4918F85F-C91D-4027-B1BB-80B6ECD4E58B</gtr:id><gtr:title>International Union of Basic and Clinical Pharmacology. XCVI. Pattern recognition receptors in health and disease.</gtr:title><gtr:parentPublicationTitle>Pharmacological reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dc38ddc2aa13707bc8b3e3c7d2d3829c"><gtr:id>dc38ddc2aa13707bc8b3e3c7d2d3829c</gtr:id><gtr:otherNames>Bryant CE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0031-6997</gtr:issn><gtr:outcomeId>56b28243c1ed49.04021321</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G1000133</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>